It is not clear that how long the affected fetuses can tolerate fetomaternal hemorrhage (FMH). Incidental serial measurements of the fetal peak systolic velocity of the middle cerebral artery and the retrospective analysis of stocked blood available incidentally indicated that our patient had suffered from FMH for at least 2 weeks prior to delivery.

BACKGROUND Fetomaternal hemorrhage (FMH) is a poorly understood condition in which the placenta allows transmission of fetal whole blood to the mother. FMH can cause fetal anemia resulting in critical illness, death or lifelong disability. Ascertainment of the incidence of FMH is limited by reliance on retrospective studies that are dependent on a diagnosis of FMH being made at the time of pati...

BACKGROUND This study aimed to assess fetomaternal hemorrhage (FMH) among RhD negative pregnant mothers using two techniques, Kleihauer-Betke (KBT) and Flow cytometry (FCM). To determine if patient-specific doses of prophylactic anti-D warrant further investigation in Ethiopia and wider Africa. METHODS Hospital- based cross-sectional study was conducted among 75 RhD negative pregnant mothers ...

Background: Quantification of fetal red blood cells (RBCs) in maternal blood is of great importance to calculate appropriate dose of post-deliver anti D immunoglobulin in a rhesus D (RhD)-negative woman. Objective: The aim of this study is to evaluate a direct immunofluorescence flow cytometry technique in artificial and clinical samples and compared it t...

objective: to analyze the trend in maternal mortality ratio in a tertiary care centre and the effect of various maternity schemes on it. materials and methods:  retrospective analysis of all maternal deaths occurring in the guru gobind singh medical college & hospital, faridkot, punjab, india was done from jan 2010 to dec 2012. every maternal death was scrutinized from various aspects like dire...

OBJECTIVES To analyze the role of middle cerebral artery (MCA) peak systolic velocity (PSV) in the prediction of severe fetomaternal hemorrhage (FMH) and to compare it with standard biophysical assessment. DATA SOURCES Retrospective review of cases of FMH seen in our unit and systematic review of the literature. RESULTS We followed the MOOSE guidelines to review the literature. From 838 art...

Maternal fetal leakage (FMH) is a well-known cause of anemia. We define it as the transition erythrocytes into maternal circulation. Its severity determined by measuring level hemoglobin in mother's blood using Kleinhauer-Betke test or cytometric method (FCM). The paper presents case newborn with massive maternal-fetal leakage. Kleinhauer result was greater than 5% cells, and initial neonatal 3...

Transplacental or fetomaternal hemorrhage (FMH) may occur during pregnancy or at delivery and lead to immunization to the D antigen if the mother is Rh-negative and the baby is Rh-positive. This can result in hemolytic disease of the fetus and newborn (HDFN) in subsequent D-positive pregnancies. The aim of this study is to highlight the challenges associated with the effective management and pr...

BACKGROUND FMH quantification is necessary to calculate an individual dose of prophylactic anti-RhD immunoglobulin and to diagnose fetal anaemia causes. We encountered a healthy woman with a numerous RBCs containing fetal haemoglobin (HbF). AIMS To investigate the cause of this sign and the correct evaluation of fetal RBCs in maternal circulation. MATERIALS AND METHODS Patients samples and ...